This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boppana, S. B.
Right arrow Articles by Pass, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boppana, S. B.
Right arrow Articles by Pass, R. F.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 104 No. 1 July 1999, pp. 55-60

Symptomatic Congenital Cytomegalovirus Infection in Infants Born to Mothers With Preexisting Immunity to Cytomegalovirus

Received Nov 25, 1998; accepted Feb 10, 1999.

Suresh B. Boppana*, Karen B. Fowler*, Dagger , William J. Britt*, §, Sergio Stagno*, §, and Robert F. Pass*, §

From the Departments of * Pediatrics, Dagger  Epidemiology, and § Microbiology, University of Alabama at Birmingham, Birmingham, Alabama.

Objectives.  To determine the frequency of symptomatic congenital cytomegalovirus (CMV) infection in the offspring of women with a recurrent maternal CMV infection and to characterize the demographic and newborn findings.

Methods.  Study subjects consisted of infants with symptomatic congenital CMV infection identified by a newborn virologic screening program at the University of Alabama Hospital between 1991 and 1997 and were enrolled in a long-term follow-up study. Maternal infections were categorized by an analysis of archival serum specimens collected before pregnancy and at the time of delivery. Demographic data and clinical findings at birth were collected from maternal and newborn hospital records and from parents at the time of initial evaluation.

Results.  Of the 47 infants with symptomatic congenital CMV infection identified during the study period, 8 were born to mothers with a confirmed nonprimary or recurrent CMV infection. The type of maternal infection could be ascertained in only ~43% (20/47) of the children with symptomatic congenital CMV infection born at the University of Alabama Hospital during the study period. There were no significant differences in demographic characteristics of the recurrent infection group and the infants who were born to mothers with either primary CMV infection during pregnancy or unclassified maternal infection. Similarly, the range of severity of clinical abnormalities during the newborn period did not differ in the two groups of children. Furthermore, there were no significant differences in the incidence of sequelae at long-term follow-up in the two groups of children.

Conclusions.  Symptomatic congenital CMV infection can occur after a nonprimary or recurrent maternal infection. However, the exact incidence of symptomatic congenital CMV infection among children born to women with preexisting immunity remains to be defined.  Key words:  cytomegalovirus, congenital infection, symptomatic, immunity, recurrent CMV infection.




This article has been cited by other articles:


Home page
 CVIHome page
E. A. Reap, S. A. Dryga, J. Morris, B. Rivers, P. K. Norberg, R. A. Olmsted, and J. D. Chulay
Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins
Clin. Vaccine Immunol., June 1, 2007; 14(6): 748 - 755.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. H. Luo, K. Rosenke, K. Czornak, and E. A. Fortunato
Human Cytomegalovirus Disrupts both Ataxia Telangiectasia Mutated Protein (ATM)- and ATM-Rad3-Related Kinase-Mediated DNA Damage Responses during Lytic Infection
J. Virol., February 15, 2007; 81(4): 1934 - 1950.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. S. Albano, P. Taylor, R. F. Pass, A. Scaradavou, R. Ciubotariu, C. Carrier, L. Dobrila, P. Rubinstein, and C. E. Stevens
Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening
Blood, December 15, 2006; 108(13): 4275 - 4282.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. C. Casavant, M. H. Luo, K. Rosenke, T. Winegardner, A. Zurawska, and E. A. Fortunato
Potential Role for p53 in the Permissive Life Cycle of Human Cytomegalovirus.
J. Virol., September 1, 2006; 80(17): 8390 - 8401.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. C. Munro, B. Hall, L. R. Whybin, L. Leader, P. Robertson, G. T. Maine, and W. D. Rawlinson
Diagnosis of and Screening for Cytomegalovirus Infection in Pregnant Women
J. Clin. Microbiol., September 1, 2005; 43(9): 4713 - 4718.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. S. Morello, M. Ye, S. Hung, L. A. Kelley, and D. H. Spector
Systemic Priming-Boosting Immunization with a Trivalent Plasmid DNA and Inactivated Murine Cytomegalovirus (MCMV) Vaccine Provides Long-Term Protection against Viral Replication following Systemic or Mucosal MCMV Challenge
J. Virol., January 1, 2005; 79(1): 159 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Z. Wang, C. La Rosa, R. Maas, H. Ly, J. Brewer, S. Mekhoubad, P. Daftarian, J. Longmate, W. J. Britt, and D. J. Diamond
Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus
J. Virol., April 15, 2004; 78(8): 3965 - 3976.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Pereira, E. Maidji, S. McDonagh, O. Genbacev, and S. Fisher
Human Cytomegalovirus Transmission from the Uterus to the Placenta Correlates with the Presence of Pathogenic Bacteria and Maternal Immunity
J. Virol., December 15, 2003; 77(24): 13301 - 13314.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Zucca, S. Binda, R. Borgatti, F. Triulzi, L. Radice, C. Butte, P. E. Barkhaus, and M. Barbi
Retrospective diagnosis of congenital cytomegalovirus infection and cortical maldevelopment
Neurology, September 9, 2003; 61(5): 710 - 712.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J.L. Bresson, M.C. Clavequin, M.C. Mazeron, C. Mengelle, C. Scieux, M. Segondy, N. Houhou, and for Federation Francaise des CECOS
Risk of cytomegalovirus transmission by cryopreserved semen: a study of 635 semen samples from 231 donors
Hum. Reprod., September 1, 2003; 18(9): 1881 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
Y Schlesinger, D Halle, A I Eidelman, D Reich, D Dayan, B Rudensky, D Raveh, D Branski, M Kaplan, V Shefer, et al.
Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2003; 88(5): F371 - F374.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. B. Fowler, S. Stagno, and R. F. Pass
Maternal Immunity and Prevention of Congenital Cytomegalovirus Infection
JAMA, February 26, 2003; 289(8): 1008 - 1011.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
M. G. Revello and G. Gerna
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Clin. Microbiol. Rev., October 1, 2002; 15(4): 680 - 715.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
S. Lipitz, R. Achiron, Y. Zalel, E. Mendelson, M. Tepperberg, and R. Gamzu
Outcome of Pregnancies With Vertical Transmission of Primary Cytomegalovirus Infection
Obstet. Gynecol., September 1, 2002; 100(3): 428 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Sequar, W. J. Britt, F. D. Lakeman, K. M. Lockridge, R. P. Tarara, D. R. Canfield, S.-S. Zhou, M. B. Gardner, and P. A. Barry
Experimental Coinfection of Rhesus Macaques with Rhesus Cytomegalovirus and Simian Immunodeficiency Virus: Pathogenesis
J. Virol., June 27, 2002; 76(15): 7661 - 7671.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. A. Fortunato, V. Sanchez, J. Y. Yen, and D. H. Spector
Infection of Cells with Human Cytomegalovirus during S Phase Results in a Blockade to Immediate-Early Gene Expression That Can Be Overcome by Inhibition of the Proteasome
J. Virol., May 3, 2002; 76(11): 5369 - 5379.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. Gouarin, E. Gault, A. Vabret, D. Cointe, F. Rozenberg, L. Grangeot-Keros, P. Barjot, A. Garbarg-Chenon, P. Lebon, and F. Freymuth
Real-Time PCR Quantification of Human Cytomegalovirus DNA in Amniotic Fluid Samples from Mothers with Primary Infection
J. Clin. Microbiol., May 1, 2002; 40(5): 1767 - 1772.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Liesnard, E. Strebelle, and Y. Englert
Screening standards in assisted reproductive technologies: Is the British Andrology Society recommendation to recruit cytomegalovirus negative semen donors only, a reasonable one?
Hum. Reprod., September 1, 2001; 16(9): 1789 - 1791.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. B. Boppana, L. B. Rivera, K. B. Fowler, M. Mach, and W. J. Britt
Intrauterine Transmission of Cytomegalovirus to Infants of Women with Preconceptional Immunity
N. Engl. J. Med., May 3, 2001; 344(18): 1366 - 1371.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. Ahlfors, S.-A. Ivarsson, S. Harris;, S. Boppana, K. B. Fowler;, and K. Ahlfors
Secondary Maternal Cytomegalovirus Infection{---}A Significant Cause of Congenital Disease
Pediatrics, May 1, 2001; 107(5): 1227 - 1228.
[Full Text]

Home page
 Hum ReprodHome page
D. E. A McLaughlin

Hum. Reprod., October 1, 2000; 15(10): 2248 - 2249.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
C. LIESNARD, C. DONNER, F. BRANCART, F. GOSSELIN, M.-L. DELFORGE, and F. RODESCH
Prenatal Diagnosis of Congenital Cytomegalovirus Infection: Prospective Study of 237 Pregnancies at Risk
Obstet. Gynecol., June 1, 2000; 95(6): 881 - 888.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. A. Fortunato, M. L. Dell'Aquila, and D. H. Spector
Specific chromosome 1 breaks induced by human cytomegalovirus
PNAS, January 18, 2000; 97(2): 853 - 858.
[Abstract] [Full Text] [PDF]